Cara Therapeutics
CARA
#10101
Rank
A$12.76 M
Marketcap
$8.37
Share price
-2.56%
Change (1 day)
665.11%
Change (1 year)

Cara Therapeutics (CARA) - P/B ratio

P/B ratio as of April 2025 : -1.77

According to Cara Therapeutics 's latest financial reports the company has a price-to-book ratio of 1.13641.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Cara Therapeutics - P/B ratio (from 2014 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31-4.51-736.66%
2023-12-310.7091-80.49%
2022-12-313.6327%
2021-12-312.86-5.49%
2020-12-313.03-24.89%
2019-12-314.034.78%
2018-12-313.85-16.35%
2017-12-314.60-7.95%
2016-12-315.0014.22%
2015-12-314.37-0.59%
2014-12-314.40
2013-12-31N/A
2012-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
-0.0463-97.38%๐Ÿ‡บ๐Ÿ‡ธ USA
1.03-158.53%๐Ÿ‡บ๐Ÿ‡ธ USA
1.43-181.26%๐Ÿ‡บ๐Ÿ‡ธ USA
5.24-396.61%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.0044-99.75%๐Ÿ‡บ๐Ÿ‡ธ USA